当前位置: X-MOL 学术Cell Biol. Toxicol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
m6A modification mediates SLC3A2/SLC7A5 translation in 3-methylcholanthrene-induced uroepithelial transformation
Cell Biology and Toxicology ( IF 6.1 ) Pub Date : 2024-01-25 , DOI: 10.1007/s10565-024-09846-9
Bixia Liu , Yifan Lv , Wenyu Hu , Yapeng Huang , Xiaoling Ying , Cong Chen , Haiqing Zhang , Weidong Ji

Abstract

3-Methylcholanthracene (3-MC) is one of the most carcinogenic polycyclic aromatic hydrocarbons (PAHs). Long-term exposure to PAHs has been thought of as an important factor in urothelial tumorigenesis. N6-methyladenosine (m6A) exists widely in eukaryotic organisms and regulates the expression level of specific genes by regulating mRNA stability, translation efficiency, and nuclear export efficiency. Currently, the potential molecular mechanisms that regulate m6A modification for 3-MC carcinogenesis remain unclear. Here, we profiled mRNA, m6A, translation and protein level using “-omics” methodologies, including transcriptomes, m6A profile, translatomes, and proteomics in 3-MC-transformed urothelial cells and control cells. The key molecules SLC3A2/SLC7A5 were screened and identified in 3-MC-induced uroepithelial transformation. Moreover, SLC7A5/SLC3A2 promoted uroepithelial cells malignant phenotype in vitro and in vivo. Mechanically, METTL3 and ALKBH5 mediated m6A modification of SLC3A2/SLC7A5 mRNA in 3-MC-induced uroepithelial transformation by upregulating the translation of SLC3A2/SLC7A5. Furthermore, programmable m6A modification of SLC3A2/SLC7A5 mRNA affected the expression of its proteins. Taken together, our results revealed that the m6A modification-mediated SLC3A2/SLC7A5 translation promoted 3-MC-induced uroepithelial transformation, suggesting that targeting m6A modification of SLC3A2/SLC7A5 may be a potential therapeutic strategy for bladder cancer related to PAHs.



中文翻译:

m6A 修饰介导 3-甲基胆蒽诱导的尿路上皮转化中的 SLC3A2/SLC7A5 翻译

摘要

3-甲基胆蒽(3-MC)是致癌性最强的多环芳烃(PAH)之一。长期接触多环芳烃被认为是尿路上皮肿瘤发生的一个重要因素。N 6 -甲基腺苷(m 6 A)广泛存在于真核生物中,通过调节mRNA稳定性、翻译效率和核输出效率来调节特定基因的表达水平。目前,调节 m 6 A 修饰促进 3-MC 致癌的潜在分子机制仍不清楚。在这里,我们使用“组学”方法对 3-MC 转化的尿路上皮细胞和对照细胞中的 mRNA、m 6 A、翻译和蛋白质水平进行了分析,包括转录组、m 6 A谱、翻译组和蛋白质组。筛选并鉴定了3-MC诱导的尿路上皮转化中的关键分子SLC3A2/SLC7A5。此外,SLC7A5/SLC3A2在体外和体内促进尿上皮细胞恶性表型。从机械角度来说,METTL3 和 ALKBH5通过上调 SLC3A2/SLC7A5 的翻译,介导 3-MC 诱导的尿路上皮转化中 SLC3A2/SLC7A5 mRNA 的m 6 A 修饰。此外,SLC3A2/SLC7A5 mRNA 的可编程 m 6 A 修饰影响其蛋白质的表达。综上所述,我们的结果表明,m 6 A 修饰介导的 SLC3A2/SLC7A5 翻译促进了 3-MC 诱导的尿上皮转化,表明针对 SLC3A2/SLC7A5 的 m 6 A 修饰可能是与 PAH 相关的膀胱癌的潜在治疗策略。

更新日期:2024-01-25
down
wechat
bug